CRAFT Behavior Therapy: Treatment Entry Component - NCT00842036-19106 (Clinical Trial 271284)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy271284.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Philadelphia |
|
State:
|
|
PA |
| Zip Code: |
|
19106 |
| Conditions: |
|
Drug Addiction - Stimulant Dependence - Opiate Dependence - Alcohol Dependence - Substance Abuse |
| Purpose: |
|
This research compares the benefits of the original treatment, Community Reinforcement and
Family Training (CRAFT), with the Treatment Entry Training (TEnT) component of CRAFT to
determine if TEnt alone can produce the primary outcome of CRAFT -- treatment entry of the
drug user. We also look at the impact on the well-being of the concerned significant other
and the drug use of their loved one.
|
| Study summary: |
|
The consequences of drug abuse are not limited to drug users; they also extend to their
families and concerned significant others (CSOs). Research shows that CSOs of drug users
have increased prevalence of illness, domestic violence, and problems in mood and
functioning. Because CSOs are troubled by the negative effects of drug use on the drug user
and themselves, they may be a social community that is particularly invested in learning
ways to positively influence the drug user.
We compare the benefits of the original treatment, Community Reinforcement and Family
Training (CRAFT), with the Treatment Entry Training (TEnT) component of CRAFT to see if the
TEnt is sufficient to produce the primary and most consistent outcome of CRAFT -- treatment
entry of the drug user. |
| Criteria: |
|
Inclusion Criteria:
- Concerned Significant Other (CSO) and Person of Concern (PC) over 18 years of age
- is a family member (such as a close relative, spouse, intimate partner), roommate or
significant other who is concerned about a PC
- reports that the PC has a pattern of drug or alcohol use that meets the criterion for
abuse or dependence on stimulants, opiates, or alcohol according to DSM-IV-TR
- reports that the PC is not currently in treatment and has not received treatment
during the past 6 weeks (other than detoxification)
- reports having been in the relationship with the identified PC for at least 3 months
- reports contact with the identified PC on at least 12 of the past 30 days with no
planned change in the amount of contact in the next 10 months
- provides evidence that the PC has refused to seek treatment when CSO asked
Exclusion Criteria:
- does not demonstrate complete understanding of their participation by reading the
consent form and passing a consent quiz that tests comprehension of the basic
elements of informed consent and requirements of the protocol, or does not agree to
participate by signing an informed consent
- declines to: provide valid locator information, allow videotaped sessions, and/or
participate in follow-ups
- CSO has a drug abuse problem themselves as determined through clinical assessment and
DSM-IV-TR criteria
- is not able to comprehend the content in the self-report materials (written at about
6th grade reading level)
- reports that the PC behaves in a manner consistent with an unremitting psychosis or
another psychiatric disorder (e.g., significant developmental delay) that would
contraindicate the planned CRAFT intervention
- intends to receive more than 6 hours of individual counseling focusing on the PC's
addiction for the 6 months after they are enrolled in the study
- PC has a recent history of severe domestic violence (e.g., the PC has committed
criminal assault during the past 2 years, or has a history of severe violence
involving a weapon or resulting in hospitalization
- has an immediate family member, friend, roommate, co-worker, or other person who has
already enrolled in the study and his/her participation is not likely to be
independent of the initially enrolled CSO's participation
- fails to complete 2 sessions with a family trainer |
|
|
|
| Study is available at: |
|
TRI South Street
Philadelphia, PA 19106
United States
Primary Contact:
Kimberly C Kirby, Ph.D.
Email: kkirby@tresearch.org
Phone: 215-399-0980 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|